Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2000
06/20/2000US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
06/20/2000US6077508 Administering a labeled molecule such as antibody that binds to a urokinase plasminogen activator receptor; delaying to allow labeled molecule to concentrate at metastatic lesion; detection above background level indicates metastatic lesion
06/20/2000US6077507 Method of making a composition comprising a fibrin monomer
06/20/2000CA2000479C Vasopermeability-enhancing conjugates
06/20/2000CA1341033C Precursor protein of apc polypeptide, dna coding for this, and diagnostic use of the dna and of the protein
06/20/2000CA1341030C Protein active in humoral hypercalcemia of malignancy-pthrp
06/15/2000WO2000034787A1 Cancer detection method and reagents
06/15/2000WO2000034786A1 DETECTION METHOD FOR $i(MICROTHRIX PARVICELLA)
06/15/2000WO2000034784A1 Protein scaffolds for antibody mimics and other binding proteins
06/15/2000WO2000034780A2 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
06/15/2000WO2000034485A2 Beta-1,3-galactosyltransferase homologs
06/15/2000WO2000034484A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
06/15/2000WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000WO2000034482A2 Novel compounds derived from neisseria meningitidis
06/15/2000WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS)
06/15/2000WO2000034477A2 Neuron-associated proteins
06/15/2000WO2000034475A2 Grnf4, a gdnf-related neurotrophic factor
06/15/2000WO2000034474A2 Growth factor homolog zvegf3
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
06/15/2000WO2000034459A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans
06/15/2000WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b
06/15/2000WO2000034436A2 Facs assisted methods for introducing individual chromosomes into cells
06/15/2000WO2000034337A1 Humanized monoclonal antibodies against vascular endothelial cell growth factor
06/15/2000WO2000034336A1 A method for detecting neuronal cell damage by quantification of map-2 levels in biological fluids
06/15/2000WO2000034335A2 'death domain' containing receptors
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000WO2000034317A2 Method for reducing immunogenicity of proteins
06/15/2000WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1')
06/15/2000WO2000033874A2 Boron neutron capture therapy using pre-targeting methods
06/15/2000WO2000033873A1 Reagent and method for detecting a cryptosporidium parvum sporozoite antigen
06/15/2000WO2000012678A3 Staphylococcus aureus genes and polypeptides
06/15/2000WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
06/15/2000WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
06/15/2000WO2000008178A3 Murine dna molecules encoding polypeptides having kinase functions
06/15/2000WO2000006726A3 Delta-related polypeptides
06/15/2000WO2000006604A3 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
06/15/2000WO2000005374A3 Molecules associated with cell proliferation
06/15/2000WO2000005253A3 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2)
06/15/2000WO2000001821A3 Neurotransmission associated proteins
06/15/2000WO1999066951A3 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
06/15/2000WO1999066051A3 Nek-related and bub1-related protein kinases
06/15/2000WO1999061452A3 acpS
06/15/2000WO1999059614A9 Modulation of angiogenesis and wound healing
06/15/2000WO1999055858A3 Human nucleic acid sequences obtained from pancreas tumor tissue
06/15/2000WO1999047669A3 Human nucleic acid sequences from tissue of breast tumors
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000WO1999002550A8 Ctl epitopes from ebv
06/15/2000CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2354702A1 Cancer detection method and reagents
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1")
06/15/2000CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2354028A1 Neisseria meningitidis basb041 polypeptides and encoding polynucleotides and uses thereof
06/15/2000CA2354026A1 Beta-1,3-galactosyltransferase homologs
06/15/2000CA2353797A1 Neuron-associated proteins
06/15/2000CA2353773A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000CA2353559A1 Facs assisted methods for introducing individual chromosomes into cells
06/15/2000CA2353526A1 Reagent and method for detecting a cryptosporidium parvum sporozoite antigen
06/15/2000CA2353525A1 Drug targets in candida albicans
06/15/2000CA2352534A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
06/15/2000CA2351562A1 A method for detecting neuronal cell damage by quantification of map-2 levels in biological fluids
06/15/2000CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3
06/15/2000CA2351346A1 Protein scaffolds for antibody mimics and other binding proteins
06/15/2000CA2342967A1 Modifying protein immunogenicity
06/14/2000EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
06/14/2000EP1008603A1 Soluble polypeptides
06/14/2000EP1007967A2 Methods for identifying ligand specific binding molecules
06/14/2000EP1007964A1 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES
06/14/2000EP1007726A1 Method and compositions for controlling gene expression
06/14/2000EP1007718A1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
06/14/2000EP1007706A1 Rna binding protein and binding site useful for expression of recombinant molecules
06/14/2000EP1007700A1 Immunological detection of prions
06/14/2000EP1007697A2 Production of proteins in eggs
06/14/2000EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof
06/14/2000EP1007695A2 Rab proteins
06/14/2000EP1007688A2 Desaturase antigen of mycobacterium tuberculosis
06/14/2000EP1007685A2 Surface exposed proteins from chlamydia pneumoniae
06/14/2000EP1007684A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
06/14/2000EP1007680A2 Single and double chain antibodies to the egf receptor, derivatives thereof and their use
06/14/2000EP1007678A1 Kringle1
06/14/2000EP1007677A2 Protease-related protein
06/14/2000EP1007676A1 High affinity immunoglobulin e receptor-like protein
06/14/2000EP1007674A1 Testis-specific transcription factor zgcl-1
06/14/2000EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems
06/14/2000EP1007671A1 Fanconi-gen ii
06/14/2000EP1007670A2 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr
06/14/2000EP1007668A1 Human pancreatitis-associated protein, pap-2
06/14/2000EP1007667A1 Nucleic acids encoding sperm antigens and reprosa-i polypeptides
06/14/2000EP1007666A1 Neurturin receptor
06/14/2000EP1007665A1 Two human homologues of galectin-5
06/14/2000EP1007663A2 Human proteins
06/14/2000EP1007659A2 Tumor necrosis factor receptors 6 alpha & 6 beta
06/14/2000EP1007650A1 Pca3, pca3 genes, and methods of use
06/14/2000EP1007645A1 Human serum inducible kinase (snk)
06/14/2000EP1007638A1 Kcnq potassium channels and methods of modulating same
06/14/2000EP1007632A1 Isolation of bone and cartilage precursor cells
06/14/2000EP1007570A1 Monospecific antibody reactive with fibrinogen and fibrinopeptide b
06/14/2000EP1007569A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE $g(a)-GALACTOSYL EPITOPE
06/14/2000EP1007567A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
1 ... 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 ... 1494